Who
Colleen Tupper
EVP & Chief Financial Officer
Company insider
Files Form 4 as: EVP & Chief Financial Officer, Collegium Pharmaceutical.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $3.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 May 2021
- Last trade
- 10 Feb 2026
- Last filed
- 12 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —26,421 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —32,734 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $555K11,861 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $1.2M26,679 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —26,421 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —32,734 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $555K11,861 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $1.2M26,679 at $46.75 | filing |
| 6 Nov 2025filed 7 Nov 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $1.0M25,142 at $40.38 | filing |
| 6 Nov 2025filed 7 Nov 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $201K4,858 at $41.28 | filing |
| 21 Mar 2025filed 24 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $192K6,396 at $30.03 | filing |
| 20 Mar 2025filed 24 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $36K1,206 at $30.00 | filing |
| 14 Mar 2025filed 18 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $29K977 at $30.00 | filing |
| 11 Mar 2025filed 13 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $313K10,445 at $30.01 | filing |
| 7 Mar 2025filed 10 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $45K1,504 at $30.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $58K1,949 at $30.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —51,768 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —26,957 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $247K8,109 at $30.52 | filing |
| 10 Feb 2025filed 12 Feb 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $681K22,317 at $30.52 | filing |
News
Head to Head Survey: Collegium Pharmaceutical (NASDAQ:COLL) versus Journey Medical (NASDAQ:DERM)COLL · dailypolitical.com · 22 Oct 2026Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Colleen Tupper; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.